Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
Guangxi Engineering Center for Organoids and Organ-on-chips of Highly Pathogenic Microbial Infections & Biosafety III laboratory, Life Science Institute, Guangxi Medical University, Nanning, People's Republic of China.
Emerg Microbes Infect. 2024 Dec;13(1):2429622. doi: 10.1080/22221751.2024.2429622. Epub 2024 Nov 23.
Identifying the prevalence and risk factors of secondary human immunodeficiency virus (HIV) transmission from people living with HIV (PLWH) to other people is crucial for ending the HIV epidemic. However, the data among antiretroviral therapy (ART) patients is limited. This study aims to assess the prevalence and risk factors of secondary HIV transmission among PLWH receiving ART by longitudinal molecular networks in China. In this study, the prevalence of secondary HIV transmission was 10.8%. The R was greater than 1 from 2017 to 2021 and peaked in 2019. PLWHs who were male sex, older age, engaged in condomless sex, experienced higher ART follow-up viral load, experienced ART medical omissions, infected with non-CRF01_AE subtype, and self-reported sexually transmitted infections (STIs) at HIV diagnosis increased the risk of secondary HIV transmission. However, those participants with higher education were less likely to be involved in secondary HIV transmission. The diagnostic age of the participants was nonlinearly associated with the risk of secondary HIV transmission, with a cutoff value of 43.13 years indicating a higher risk of secondary HIV transmission for patients diagnosed at or above this age. This study revealed substantial secondary HIV transmission and persistent HIV expansion among local PLWH, highlighting the necessity of enhancing viral load monitor, promoting adherence to ART, and promoting safe sex practices, particularly among older adults with HIV, to mitigate secondary HIV transmission.
确定接受抗逆转录病毒疗法 (ART) 的艾滋病毒感染者 (PLWH) 向其他人传播继发性 HIV 的流行率和风险因素对于终结 HIV 流行至关重要。然而,ART 患者的数据有限。本研究旨在通过中国纵向分子网络评估接受 ART 的 PLWH 中继发性 HIV 传播的流行率和风险因素。
在这项研究中,继发性 HIV 传播的流行率为 10.8%。2017 年至 2021 年,R 值大于 1,并在 2019 年达到峰值。男性、年龄较大、无保护性行为、ART 随访病毒载量较高、ART 医疗疏漏、感染非 CRF01_AE 亚型以及 HIV 诊断时自我报告性传播感染 (STI) 的 PLWH 增加了继发性 HIV 传播的风险。然而,受教育程度较高的参与者不太可能参与继发性 HIV 传播。参与者的诊断年龄与继发性 HIV 传播的风险呈非线性相关,诊断年龄为 43.13 岁或以上的患者具有更高的继发性 HIV 传播风险。
本研究揭示了本地 PLWH 中存在大量继发性 HIV 传播和持续的 HIV 扩张,这强调了加强病毒载量监测、促进 ART 依从性以及促进安全性行为的必要性,特别是对于年龄较大的 HIV 感染者,以减轻继发性 HIV 传播。